Navigation Links
Chronic disease research awarded funding
Date:1/15/2013

A new initiative to understand chronic disease in Africa has been awarded five years' funding by the Medical Research Council (MRC). The African Partnership for Chronic Disease Research (APCDR) is an international research partnership that assesses the burden and causes of non-communicable diseases such as diabetes and heart disease in sub-Saharan Africa.

This MRC funding will allow researchers from the partnership to develop a sustainable platform to share resources and skills which will help develop long-term strategies for disease control and management in sub-Saharan Africa.

As treatment and management of infectious diseases such as HIV, malaria and tuberculosis improves, medical researchers expect that non-infectious chronic diseases will become an increasingly important problem in sub-Saharan Africa. Diseases such as type 2 diabetes and cardiovascular disease are expected to become the leading causes of morbidity and death in this region.

The APCDR will conduct research that will provide more reliable and precise information on disease burden, underlying aetiology and strategies for intervention.

"We don't fully understand the magnitude and distribution of risk factors for these diseases in sub-Saharan Africa," says Dr Elizabeth Young, investigator from the Wellcome Trust Sanger Institute. "Over the next five years, our partnership expects to collect detailed health and disease information and blood samples from over 24,000 individuals across 10 countries. This collection will generate a resource that will provide a unique framework for researchers in these countries."

In existing studies into these diseases throughout Africa, scientists have used a variety of methods and assessed only a small subset of risk factors. This small scale restricts any comparative studies across the region.

This partnership will develop the much needed, large-scale high quality comparable studies across a wide range of diseases and possible risk factors, spanning countries across sub-Saharan Africa. Importantly, this will also provide a platform for interventional research and ensure that African populations benefit from the on-going advances in genomics.

"The African Genome Variation project, a key endeavour of the APCDR, will be an important resource for Africa researchers." says Dr Manjinder Sandhu, lead investigator from Wellcome Trust Sanger Institute and the University of Cambridge. "This will allow researchers to understand patterns of genetic diversity within sub-Saharan populations, as well as providing a global resource for genomic studies of diseases in Africa. If we want to have lasting benefits, the APCDR must provide mechanisms and infrastructure to share research resources, training and support with the next generation of researchers and scientific leaders in Africa."

"Understanding the cause and determinants of these diseases in sub-Saharan Africa is a fundamental step in developing strategies for diseases management and control," says Professor Pontiano Kaleebu, lead investigator from the MRC/UVRI Uganda Research Unit on AIDS. "In the context of epidemiological transition and the complex relation between risk factors for chronic infection and non-communicable disease, an integrated approach to our research is essential."

"For countries in sub-Saharan Africa to benefit from future progress in non-communicable disease research and genomics, there is a need to strengthen research capacity, training and collaboration across the region to ensure researchers can play a full part," says Professor Jean Claude Mbanya, lead investigator from the University of Yaounde, Cameroon. "This initiative will play an important role in piecing together the puzzle of non-communicable disease in Africa."

"The MRC is pleased to support such an innovative strategic partnership between UK scientists and centres of research excellence in sub-Saharan Africa," says Dr Wendy Ewart, MRC Deputy Chief Executive and Director of Strategy. "This award will provide a platform to enhance training and capacity building at the African centres as well as maximising outputs from world-leading collaborative research. Ultimately this will help researchers to develop effective strategies to tackle the grand challenge of non-communicable diseases in Africa."


'/>"/>
Contact: Aileen Sheehy
press.office@sanger.ac.uk
0044-012-234-92368
Wellcome Trust Sanger Institute
Source:Eurekalert

Related biology news :

1. Genetic mutation found in familial chronic diarrhea syndrome
2. Effect of chronic exposure to chemicals used as weapons, pesticides under study
3. BYU engineers conceive disc replacement to treat chronic low back pain
4. Neuroprotective dietary supplements for chronic spinal cord injury
5. Why chronic pain is all in your head
6. Chronic inflammation in the brain leads the way to Alzheimers disease
7. miR loss may power maligant transformation in chronic leukemia
8. How chronic obstructive pulmonary disease increases risk of lung cancer
9. Basal cell carcinoma risk can be chronic
10. Chronic 2000-04 drought, worst in 800 years, may be the new normal
11. Bacteria-immune system fight can lead to chronic diseases, study suggests
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/3/2017)...  Texas Biomedical Research Institute announced that its Board of ... as the Institute,s new President and CEO. Dr. Schlesinger will ... He is currently the Chair of the Department of Microbial ... Interface Biology at Ohio State University. "We are ... CEO of Texas Biomed," said Dr. James O. Rubin ...
(Date:2/2/2017)... 2, 2017  EyeLock LLC, a market leader of ... paper " What You Should Know About Biometrics in ... user authenticity is a growing concern. In traditional schemes, ... However, traditional authentication schemes such as username/password suffer from ... authentication offers an elegant solution to the problem of ...
(Date:1/31/2017)... CAMBRIDGE, Mass. , Jan. 31, 2017 /PRNewswire-USNewswire/ ... develop novel therapies for the treatment of bacterial ... generation set of antibacterial candidates from Pro Bono ... the increased prevalence of multi-drug resistant forms of ... by Cantab Anti Infectives Ltd, a PBB group ...
Breaking Biology News(10 mins):
(Date:2/23/2017)... , Feb. 23, 2017  In Atlanta, it seems everyone ... and culture intertwine to create an expressive and dynamic community ... this energy and contribute to it. With ... Hair Fairies seeks to carry on that tradition with ... Atlanta salon is the newest of 13 ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... 12th annual Inventors Recognition Reception at Purdue Research Park of West ... member in recognition of outstanding contributions to, and success with, commercializing discoveries from ...
(Date:2/23/2017)... SAN FRANCISCO , Feb. 23, 2017 ... company, and Beyond Type 1, a not-for-profit advocacy and ... today announced a grant from Beyond Type 1 to ... type 1 and other insulin-requiring diabetes.  ... innovative stem cell-derived cell replacement therapies with a focus ...
(Date:2/22/2017)... , Feb. 22, 2017  PrimeVax Immuno-Oncology, Inc. ... be presenting at the Annual Biocom Global Life Science ... 2, at 11:15 AM, at the Torrey Pines Lodge, ... to the organizers at Biocom who have chosen our ... symposium of biotechnology companies, investors, and clinical researchers," said ...
Breaking Biology Technology: